STOCK TITAN

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) will host a conference call and webcast on May 7, 2024, to discuss the financial results for the first quarter of 2024. The company focuses on CNS disorder therapeutics. Participants can register online to join the call and access the webcast through the Investor Relations section on the company's website.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) organizzerà una teleconferenza e un webcast il 7 maggio 2024 per discutere i risultati finanziari del primo trimestre del 2024. La società si concentra sui farmaci per i disturbi del sistema nervoso centrale. I partecipanti possono registrarsi online per partecipare alla chiamata e accedere al webcast tramite la sezione Relazioni con gli Investitori sul sito web dell'azienda.
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) llevará a cabo una conferencia telefónica y un webcast el 7 de mayo de 2024 para discutir los resultados financieros del primer trimestre de 2024. La compañía se especializa en terapéuticas para trastornos del sistema nervioso central. Los participantes pueden registrarse en línea para unirse a la llamada y acceder al webcast a través de la sección de Relaciones con los Inversores en el sitio web de la empresa.
Intra-Cellular Therapies, Inc. (나스닥: ITCI)는 2024년 5월 7일에 2024년 첫 분기 재무 결과에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트를 개최할 예정입니다. 이 회사는 중추신경계 장애 치료제를 중점적으로 다룹니다. 참가자들은 회사 웹사이트의 투자자 관계 섹션을 통해 컨퍼런스 콜에 참여하고 웹캐스트에 접속하기 위해 온라인으로 등록할 수 있습니다.
Intra-Cellular Therapies, Inc. (Nasdaq : ITCI) organisera une conférence téléphonique et un webcast le 7 mai 2024 pour discuter des résultats financiers du premier trimestre de 2024. L'entreprise se concentre sur les thérapeutiques pour les troubles du système nerveux central. Les participants peuvent s'inscrire en ligne pour rejoindre l'appel et accéder au webcast via la section Relations Investisseurs du site web de l'entreprise.
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) wird am 7. Mai 2024 einen Conference Call und ein Webcast abhalten, um die Finanzergebnisse für das erste Quartal 2024 zu besprechen. Das Unternehmen konzentriert sich auf Therapeutika für ZNS-Erkrankungen. Teilnehmer können sich online registrieren, um am Anruf teilzunehmen und den Webcast über den Bereich Investor Relations auf der Website des Unternehmens zu erreichen.
Positive
  • None.
Negative
  • None.

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, May 7, 2024, to provide a corporate update and discuss details of the Company's financial results for the quarter ended March 31, 2024.

To attend the live conference call by phone please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406


FAQ

When will Intra-Cellular Therapies host the conference call for the first quarter 2024 financial results?

Intra-Cellular Therapies will host the conference call on Tuesday, May 7, 2024, at 8:30 a.m. Eastern Time.

What is the focus of Intra-Cellular Therapies as a company?

Intra-Cellular Therapies is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders.

Where can participants access the webcast and conference call details?

Participants can access the webcast and conference call details on the Investor Relations section of Intra-Cellular Therapies' website at www.intracellulartherapies.com.

Intra-Cellular Therapies, Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

6.90B
94.59M
2.51%
99.05%
3.58%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NEW YORK

About ITCI

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.